tiprankstipranks
Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market
QNCX
Quince Therapeutics
RESEARCH TOOLSreports
Want to see QNCX full AI Analyst Report?

Quince Therapeutics (QNCX) Financial Statements

1,050 Followers

Quince Therapeutics Financial Overview

Quince Therapeutics's market cap is currently $21.03M. The company's EPS TTM is $-0.175; its P/E ratio is -2.00; Quince Therapeutics is scheduled to report earnings on March 3, 2026, and the estimated EPS forecast is $-1.56. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -142.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -50.43M$ -57.28M$ -34.62M$ -52.02M$ -90.32M
EBITDA$ -50.29M$ -35.98M$ -26.82M$ -50.99M$ -89.97M
Net Income$ -83.98M$ -56.83M$ -31.39M$ -51.66M$ -89.94M
Balance Sheet
Cash & Short-Term Investments$ 17.75M$ 40.78M$ 75.06M$ 90.18M$ 106.80M
Total Assets$ 93.52M$ 114.48M$ 180.20M$ 103.91M$ 133.23M
Total Debt$ 18.36M$ 14.81M$ 13.81M$ 453.00K$ 1.16M
Net Debt$ 12.55M$ 8.60M$ -6.94M$ -44.13M$ -68.56M
Total Liabilities$ 129.24M$ 84.33M$ 95.12M$ 3.32M$ 14.64M
Stockholders' Equity$ -35.71M$ 30.15M$ 85.08M$ 100.59M$ 118.59M
Cash Flow
Free Cash Flow$ -41.78M$ -32.16M$ -18.45M$ -44.17M$ -63.11M
Operating Cash Flow$ -41.42M$ -31.90M$ -18.29M$ -44.04M$ -62.93M
Investing Cash Flow$ 23.23M$ 21.91M$ -5.76M$ 18.00M$ 58.95M
Financing Cash Flow$ 17.91M$ -4.78M$ 143.00K$ 707.00K$ 6.81M
Currency in USD

Quince Therapeutics Earnings and Revenue History

Income Statement >

Quince Therapeutics Debt to Assets

Balance Sheet >

Quince Therapeutics Cash Flow

Cash Flow >

Quince Therapeutics Forecast EPS vs Actual EPS

Earnings >